These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6144513)

  • 1. [Peptides and anxiety].
    Dantzer R
    Encephale; 1983; 9(4 Suppl 2):177B-182B. PubMed ID: 6144513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of substance P in stress and anxiety responses.
    Ebner K; Singewald N
    Amino Acids; 2006 Oct; 31(3):251-72. PubMed ID: 16820980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
    McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
    Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety-like behavior induced by IL-1beta is modulated by alpha-MSH through central melanocortin-4 receptors.
    Cragnolini AB; Schiöth HB; Scimonelli TN
    Peptides; 2006 Jun; 27(6):1451-6. PubMed ID: 16325304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.
    Crespi F
    J Neurosci Methods; 2009 May; 180(1):97-105. PubMed ID: 19427535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The present status of benzodiazepines in psychopharmacology.
    Iversen LL
    Arzneimittelforschung; 1980; 30(5a):907-10. PubMed ID: 6106495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior.
    Hlavacova N; Jezova D
    Horm Behav; 2008 Jun; 54(1):90-7. PubMed ID: 18377905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like effect of neuropeptide S in the rat defensive burying.
    Vitale G; Filaferro M; Ruggieri V; Pennella S; Frigeri C; Rizzi A; Guerrini R; Calò G
    Peptides; 2008 Dec; 29(12):2286-91. PubMed ID: 18793688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of corticotropin-releasing factor (CRF) in anxiety.
    Krysiak R; Obuchowicz E; Herman ZS
    Pol J Pharmacol; 2000; 52(1):15-25. PubMed ID: 10949116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of anxiety and benzodiazepine actions.
    Iversen SD
    Arzneimittelforschung; 1980; 30(5a):862-8. PubMed ID: 6106486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
    Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
    Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ
    J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
    Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The benzodiazepine receptor: the enigma of the endogenous ligand].
    Pélissolo A
    Encephale; 1995; 21(2):133-40. PubMed ID: 7781584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic profiles.
    Gershon S; Eison AS
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):45-57. PubMed ID: 6139369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional aspects of the interaction between benzodiazepines and their central receptors].
    Soubrié P
    Encephale; 1983; 9(4 Suppl 2):183B-190B. PubMed ID: 6327228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
    Briones-Aranda A; López-Rubalcava C; Picazo O
    Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.